Invesco Pharmaceuticals ETF (PJP) Stock Price & Analysis
Invesco Pharmaceuticals ETF (PJP) closed at USD 125.03 on Friday, October 23, 2026, down 1.79% on the day. The US market is currently closed (after-hours); this is not a live price.
The prior close was USD 127.31; the Oct 23, 2026 session ranged USD 125–126.19 on volume of 6,133 shares. Market capitalization is —, with a 52-week range of USD 94.89–131.68 (PCX). Source: Nexqual, retrieved October 23, 2026 at 20:44 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PJP.md
Key facts (PJP)
- Total return with dividends: 1Y +32.9% vs S&P 500 +13.4%; 5Y +66.3% vs S&P 500 +76.9%.
Total return (dividends reinvested) (PJP)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +32.9% | +66.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +33.0% | +10.7% |
| Volatility (annualized) | 17.5% | 16.1% |
| Max drawdown | -9.4% (Feb 2026→Mar 2026) | -17.5% (Apr 2022→Oct 2023) |
PJP options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 22.8% | ±5.4% |
| Dec 18, 2026 | 56 | 19.3% | ±6.0% |
| Feb 19, 2027 | 119 | 19.9% | ±9.1% |
| May 21, 2027 | 210 | 19.5% | ±11.8% |
30-day implied volatility 20% vs 19% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 20:44 UTC)
| Price | USD 125.03 |
|---|---|
| Change | ▼ 1.79% (down) |
| Previous Close | USD 127.31 |
| Open | USD 126.66 |
| Day Range | USD 125 – 126.19 |
| 52-Week Range | USD 94.89 – 131.68 |
| Volume | 6,133 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PJP)
Nexqual's technical model rates PJP "BUY" based on 4 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 20:44 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.28 (neutral) |
| vs SMA50 | Below (USD 125.83) |
| MACD | 0.2 (positive) |
Financial Health Score (PJP)
Nexqual rates Invesco Pharmaceuticals ETF's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 20:44 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome | USD 98.72 | ▼ 0.67% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.51 | ▼ 2.17% |
| XPH | State Street SPDR S&P Pharmaceu | USD 62.7 | ▼ 2.46% |
| PBJ | Invesco Food & Beverage ETF | USD 47.93 | ▼ 1.03% |
| FBT | First Trust Amex Biotech Index | USD 269.25 | ▼ 1.26% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 20:44 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt